Krystal Biotech Inc at Bank of America Biotech SMID Cap Conference Transcript
All right. Great. Hey, everyone. Good afternoon, and welcome to day 1 of the 2022 Bank of America's mid Biotech Conference. Thanks for joining the session with Krystal Biotech. My name is Alec Stranahan, and I'm Vice President and Senior Biotech analyst covering Krystal here at BofA. I'm pleased to be joined today by Krish Krishnan, Chairman and Chief Executive Officer of Krystal. Krish, thanks for joining.
Thanks for having me, Alec.
Questions & Answers
Perfect. So this will be a fireside type of format, mostly question-and-answer. I've got a few here, but for those on the line, feel free to submit your questions via the Veracast platform, and I'll read them off anonymously as we go along. So Krish, maybe just to start on VYJUVEK. Maybe we can just do a quick recap of the sort of late
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |